Silver Nanoparticles: Biosynthesis Using an ATCC Reference Strain of<i> Pseudomonas aeruginosa</i> and Activity as Broad Spectrum Clinical Antibacterial Agents

<div>Time-death curves for<i> S. aureus</i> ATCC 29213 (-○-) and<i> E. coli</i> ATCC 25922 (-□-) using 0.6 pM Ag-NPs biosynthesized.</div>

International Journal of Biomaterials

fig5

Figure 5

Figure 5: Silver Nanoparticles: Biosynthesis Using an ATCC Reference Strain of<i> Pseudomonas aeruginosa</i> and Activity as Broad Spectrum Clinical Antibacterial Agents 

Figure 5 | Silver Nanoparticles: Biosynthesis Using an ATCC Reference Strain of Pseudomonas aeruginosa and Activity as Broad Spectrum Clinical Antibacterial Agents 